Last reviewed · How we verify

clindamycin 1% / benzoyl peroxide 5% tube

Sanofi · FDA-approved active Small molecule

clindamycin 1% / benzoyl peroxide 5% tube is a Topical antibiotic combination Small molecule drug developed by Sanofi. It is currently FDA-approved for Acne vulgaris.

Clindamycin kills acne-causing bacteria while benzoyl peroxide reduces sebum production and provides additional antimicrobial and keratolytic effects.

Clindamycin kills acne-causing bacteria while benzoyl peroxide reduces sebum production and provides additional antimicrobial and keratolytic effects. Used for Acne vulgaris.

At a glance

Generic nameclindamycin 1% / benzoyl peroxide 5% tube
SponsorSanofi
Drug classTopical antibiotic combination
TargetBacterial 50S ribosome (clindamycin); reactive oxygen species generation (benzoyl peroxide)
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effectively killing Propionibacterium acnes. Benzoyl peroxide is an oxidizing agent that generates reactive oxygen species to kill bacteria and also helps normalize keratinization and reduce sebaceous gland activity. Together, they provide synergistic antibacterial and anti-inflammatory effects for acne treatment.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about clindamycin 1% / benzoyl peroxide 5% tube

What is clindamycin 1% / benzoyl peroxide 5% tube?

clindamycin 1% / benzoyl peroxide 5% tube is a Topical antibiotic combination drug developed by Sanofi, indicated for Acne vulgaris.

How does clindamycin 1% / benzoyl peroxide 5% tube work?

Clindamycin kills acne-causing bacteria while benzoyl peroxide reduces sebum production and provides additional antimicrobial and keratolytic effects.

What is clindamycin 1% / benzoyl peroxide 5% tube used for?

clindamycin 1% / benzoyl peroxide 5% tube is indicated for Acne vulgaris.

Who makes clindamycin 1% / benzoyl peroxide 5% tube?

clindamycin 1% / benzoyl peroxide 5% tube is developed and marketed by Sanofi (see full Sanofi pipeline at /company/sanofi).

What drug class is clindamycin 1% / benzoyl peroxide 5% tube in?

clindamycin 1% / benzoyl peroxide 5% tube belongs to the Topical antibiotic combination class. See all Topical antibiotic combination drugs at /class/topical-antibiotic-combination.

What development phase is clindamycin 1% / benzoyl peroxide 5% tube in?

clindamycin 1% / benzoyl peroxide 5% tube is FDA-approved (marketed).

What are the side effects of clindamycin 1% / benzoyl peroxide 5% tube?

Common side effects of clindamycin 1% / benzoyl peroxide 5% tube include Skin irritation, Dryness, Erythema, Peeling, Contact dermatitis.

What does clindamycin 1% / benzoyl peroxide 5% tube target?

clindamycin 1% / benzoyl peroxide 5% tube targets Bacterial 50S ribosome (clindamycin); reactive oxygen species generation (benzoyl peroxide) and is a Topical antibiotic combination.

Related